Top

Published in:

01-12-2018 | IM - COMMENTARY

Reducing carbapenem prescribing in high-use settings: it is possible, and it is good to talk

Author: Nicola Jane Fawcett

Published in: Internal and Emergency Medicine | Issue 8/2018

Excerpt

The importance of reducing unnecessary use of antibiotics, especially our ‘last line’ agents, cannot be overstated. Higher use of carbapenems at a country and institutional level has been shown to correlate with higher rates of resistance [1], and carbapenem use at a patient level is associated with risk of resistant infection [2]. Yet overuse of these crucial antibiotics is widespread. Changing, and reducing, antibiotic use has proved a major challenge, so success stories are welcome. …

McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH (2013) Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae. Antimicrob Agents Chemother 57:5131–5133CrossRef

Falagas ME, Rafailidis PI, Kofteridis D et al (2007) Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother 60:1124–1130CrossRef

Fortini A, Faraone A, Di Pietro M et al (2018) Antimicrobial stewardship in an Internal Medicine ward: effects on antibiotic consumption and on the use of carbapenems. Intern Emerg Med

Davey P, Marwick CA, Scott CL et al (2017) Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2:CD003543PubMed

Pinder RJ, Sallis A, Berry D, Chadborn T (2015) Behaviour change and antibiotic prescribing in healthcare settings: literature review and behavioural analysis. Department of Health, Public Health England, London. https://doi.org/10.13140/RG.2.1.4657.4245

Title: Reducing carbapenem prescribing in high-use settings: it is possible, and it is good to talk
Author: Nicola Jane Fawcett
Publication date: 01-12-2018
Publisher: Springer International Publishing
Published in: Internal and Emergency Medicine / Issue 8/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI: https://doi.org/10.1007/s11739-018-1959-y

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Reducing carbapenem prescribing in high-use settings: it is possible, and it is good to talk

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 8/2018

Hazelnut-enriched chocolate improves flow-mediated artery dilatation via inhibition of oxidative stress

Perioperative care of cardiac patient’s candidate for non-cardiac surgery: a critical appraisal of emergent evidence and international guidelines

Chronic hyponatremia in a patient with renal salt wasting and without cerebral disease: relationship between RSW, risk of fractures and cognitive impairment

Extreme hypomagnesemia: underrecognized and underappreciated

Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia

In-flight cardiac arrest and in-flight cardiopulmonary resuscitation during commercial air travel: consensus statement and supplementary treatment guideline from the German Society of Aerospace Medicine (DGLRM)

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page